Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > QIXLEEF™ MIGHT be an effective analgesic for pain management

<< Previous

Bullboard Posts

Next >>

Post by SamV21on Mar 20, 2022 1:35pm

105 Views

Post# 34529637

QIXLEEF™ MIGHT be an effective analgesic for pain management

Amazing how you change the words in a post from might ,as is says in the original news release to is , it also says reduce opioid use NOT replace.
We all know you exaggerate news just to try and pump on no results , its all just noise with no results.
I am thinking news release before the market opens tomorrow as 2 million shares traded in the last minute on Friday , this could be good or it could be bad , maybe a raise at .05 once again Guy knows something we shareholders are not being told and someone else knows what is happening tomorrow and either bought or shorted the stock.

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December